Type 2 diabetes is the most common form.
Type 2 diabetes is a long-term condition that impairs your glucose metabolism. Pancreas makes insulin, a hormone that transports glucose into your cells to be used as energy. Insulin works by lowering the amount of sugar in your blood stream, while the pancreas slows the production and release of insulin when your blood sugar drops.
Insulin resistance is the initial symptom of type 2 diabetes, which means your body resists the effects of insulin. In response, your pancreas produces more insulin to get the sugar into the cells. Eventually, when the pancreas can no longer keep up, glucose builds up in the blood.
The beta cells in the pancreas are responsible for producing insulin. They work harder to produce enough insulin to transport the sugar into the cells, but the beta cells eventually break down, transmitting the wrong amount of insulin at the wrong time.
Over time, your beta cells may wear out completely, and you will no longer be able to produce any insulin.
Sugar (glucose) is the main source of energy for cells. Glucose comes from food and is also produced in your liver.
Your liver stores and produces glucose. When your body needs more sugar, it signals the liver to produce and send out more glucose, which keeps your blood sugar within a normal range.
The sugar from your food is used and the liver slows down the production of sugar and stores any excess sugar from the food you ate. In type 2 diabetes patients, this mechanism can fail, causing the liver to continue to send sugar into the blood stream.
Many patients with type 2 diabetes suffers with metabolic syndrome. A medical term used to describe a group of conditions including hyperglycemia, high blood pressure, high cholesterol and high triglycerides.
Current standard care therapies are unable to reverse type 2 diabetes.
Researchers have shown mesenchymal stem cells (MSCs) have the potential to treat many chronic diseases, including type 2 diabetes.
MSCs have the ability to differentiate, self-renew, suppress the immune system, reduce inflammation, repair tissue, and are considered an ideal choice for the treatment of type 2 diabetes.1
Mesenchymal stem cells have the ability to:
The Stem Cells Transplant Institute uses mesenchymal stem cells for the treatment of type 2 diabetes. Mesenchymal stem cells have a number of advantages over other types of stem cells, including the ability to migrate to sites of tissue injury, a strong immunosuppressive effect, and better safety after infusion.
For optimal results, the Stem Cells Transplant Institute recommends a one-day treatment with human umbilical cord stem cells (hUC-MSCs) for type 2 diabetes. If the patient prefers, autologous stem cells from their own adipose tissue or bone marrow can be used. Both treatments will include the following:
Mesenchymal stem cells are a promising treatment for diabetes mellitus. Treatment at the Stem Cells Transplant Institute may improve the symptoms and long-term complications of type 2 diabetes.
Our clinic focuses on obtaining healthy stem cells exclusively from umbilical cord blood donors. We collect the placenta once the baby is born, with the parent’s informed consent. Additionally, we follow strict ethical guidelines and collect stem cells from reliable and reputable sources.
Our nursing staff administers the stem cells through an intravenous and intra-pulmonary route. For the most effective outcomes, intravenous administration is preferred.
Our clinic is located in Costa Rica, which is one of the most popular medical tourism destinations for stem cell therapy. At the Stem Cells Transplant Institute, we have a skilled team of doctors and medical professionals who collect and administer stem cells to treat autism and other conditions. Every patient receives the most cost-effective and top-notch care from our dedicated team.